The U.S. Food and Drug Administration has approved Elanco Animal Health's skin disease treatment for dogs, the health ...

Sanofi said on Friday that its multiple sclerosis drug candidate was shown to delay worsening of a progressive form of the ...

For many children eczema is mild and easily controlled but for others it can be severe - causing hot, painful rashes and ...

Out of sight, out of mind” does not apply to Marc Leviste when it comes to Kris Aquino. Even if they have parted ways, the ...

EMA committee recommends approval of Sanofi & Regeneron’s Dupixent to treat eosinophilic esophagitis in children as young as 1 year old: Paris Monday, September 23, 2024, 11:00 ...

The canine atopic dermatitis treatment market is set to experience notable growth, with an expected increase from USD ...

The FDA announced earlier today that ilunocitinib tablets (Zenrelia; Elanco) has received its approval. The latest drug from ...

Paris: Sanofi has announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has ...

Immunosuppressive therapy may help reduce gastrointestinal (GI) symptoms among patients with systemic sclerosis (SSc), according to study results published in RMD Open.

Sanofi is pursuing several opportunities in MS, a debilitating nerve disease, to offset revenue losses after the recent end ...

Aurinia Pharma's LUPKYNIS is well-positioned to become a new standard of care. Read why I think AUPH stock is a strong buy.

Dupixent recommended for EU approval by the CHMP to treat eosinophilic esophagitis in children as young as 1 year old Recommendation based on a ...